pentetic acid has been researched along with Hepatolenticular Degeneration in 2 studies
Pentetic Acid: An iron chelating agent with properties like EDETIC ACID. DTPA has also been used as a chelator for other metals, such as plutonium.
Hepatolenticular Degeneration: A rare autosomal recessive disease characterized by the deposition of copper in the BRAIN; LIVER; CORNEA; and other organs. It is caused by defects in the ATP7B gene encoding copper-transporting ATPase 2 (EC 3.6.3.4), also known as the Wilson disease protein. The overload of copper inevitably leads to progressive liver and neurological dysfunction such as LIVER CIRRHOSIS; TREMOR; ATAXIA and intellectual deterioration. Hepatic dysfunction may precede neurologic dysfunction by several years.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| O'Reilly, S | 1 |
| Bank, W | 1 |
| Strickland, GT | 1 |
| Blackwell, RQ | 1 |
| Watten, RH | 1 |
2 other studies available for pentetic acid and Hepatolenticular Degeneration
| Article | Year |
|---|---|
New oral chelating agent for treatment of Wilson's disease.
Topics: Administration, Oral; Chelating Agents; Copper; Feces; Hepatolenticular Degeneration; Humans; Pentet | 1966 |
Metabolic studies in Wilson's disease. Evaluation of efficacy of chelation therapy in respect to copper balance.
Topics: Adolescent; Adult; Chelating Agents; Child; Copper; Diet Therapy; Evaluation Studies as Topic; Femal | 1971 |